Department of Medicinal Chemistry, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1278-83. doi: 10.1016/j.bmcl.2009.11.075. Epub 2009 Nov 20.
The syntheses and SAR investigations of novel CB(1) receptor antagonists based on a 1,2-diaryl piperidine core have been described. Optimization of this core afforded a compound with robust in vivo potency by reducing food intake in a mouse DIO model.
已经描述了基于 1,2-二芳基哌啶核心的新型 CB(1)受体拮抗剂的合成和 SAR 研究。通过降低肥胖小鼠模型中的食物摄入量,对该核心结构进行优化得到了一种具有强大体内活性的化合物。